Trial Profile
Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus (Primary) ; Corticosteroids; Mycophenolic acid
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma China
- 03 Aug 2022 Status changed from active, no longer recruiting to completed.
- 20 Jan 2022 Status changed from recruiting to active, no longer recruiting.
- 27 Apr 2021 Planned End Date changed from 30 Jul 2022 to 31 Jul 2022.